Clinical Trials · NCT07354880
Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Enrollment
- 30
- Start date
- Jan 2026
- Locations
- See registry
- Primary endpoint
- Change in exercise capacity after 6 months of treatment with tirzepatide.